AR027963A1 - Composicion para prevencion y/o tratamiento de los efectos citotoxicos inducidos por el uso de agentes inmunosupresores - Google Patents

Composicion para prevencion y/o tratamiento de los efectos citotoxicos inducidos por el uso de agentes inmunosupresores

Info

Publication number
AR027963A1
AR027963A1 ARP010100885A ARP010100885A AR027963A1 AR 027963 A1 AR027963 A1 AR 027963A1 AR P010100885 A ARP010100885 A AR P010100885A AR P010100885 A ARP010100885 A AR P010100885A AR 027963 A1 AR027963 A1 AR 027963A1
Authority
AR
Argentina
Prior art keywords
prevention
treatment
composition
cytotoxic effects
effects induced
Prior art date
Application number
ARP010100885A
Other languages
English (en)
Original Assignee
Sigma Tau Healthscience Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Healthscience Spa filed Critical Sigma Tau Healthscience Spa
Publication of AR027963A1 publication Critical patent/AR027963A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ARP010100885A 2000-03-02 2001-02-27 Composicion para prevencion y/o tratamiento de los efectos citotoxicos inducidos por el uso de agentes inmunosupresores AR027963A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2000RM000107A IT1316998B1 (it) 2000-03-02 2000-03-02 Composizione per la prevenzione e/o il trattamento degli effetticitotossici indotti dall'uso di agenti immunosoppressori.

Publications (1)

Publication Number Publication Date
AR027963A1 true AR027963A1 (es) 2003-04-16

Family

ID=11454493

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010100885A AR027963A1 (es) 2000-03-02 2001-02-27 Composicion para prevencion y/o tratamiento de los efectos citotoxicos inducidos por el uso de agentes inmunosupresores

Country Status (19)

Country Link
US (1) US7897641B2 (es)
EP (1) EP1267863B1 (es)
AR (1) AR027963A1 (es)
AT (1) ATE335476T1 (es)
AU (2) AU2001241031B8 (es)
CA (1) CA2400728C (es)
CY (1) CY1106169T1 (es)
CZ (1) CZ20022759A3 (es)
DE (1) DE60122120T2 (es)
DK (1) DK1267863T3 (es)
ES (1) ES2269356T3 (es)
HU (1) HUP0300083A3 (es)
IT (1) IT1316998B1 (es)
MX (1) MXPA02008531A (es)
PL (1) PL202682B1 (es)
PT (1) PT1267863E (es)
SK (1) SK11892002A3 (es)
TN (1) TNSN01032A1 (es)
WO (1) WO2001064204A2 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106232114B (zh) * 2014-04-22 2022-03-18 味之素株式会社 周围神经病变的预防或改善用组合物
CN115469026B (zh) * 2022-07-14 2023-10-20 中日友好医院(中日友好临床医学研究所) 用于检测环孢素a肾毒性相关标志物的检测试剂、试剂盒及其用途

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1120033B (it) * 1979-10-05 1986-03-19 Sigma Tau Ind Farmaceuti Composizione farmaceutica comprendente-carnitina adatta per l'alimentazione parenterale
US5290538A (en) * 1988-12-22 1994-03-01 Skrezek Christian Nephro protective infusion solutions
JPH0662547B2 (ja) * 1989-01-10 1994-08-17 田辺製薬株式会社 グリシン誘導体
IT1248323B (it) * 1991-05-16 1995-01-05 Sigma Tau Ind Farmaceuti Ammidi con amminoacidi naturali di alcanoil l-carnitine quali inibitori della degenerazione neuronale e attivatori dei processi di apprendimento e memorizzazione e per il trattamento del coma e composizioni farmaceutiche comprendenti tali composti
IT1245869B (it) 1991-06-05 1994-10-25 Sigma Tau Ind Farmaceuti Impiego di propionil l-carnitina per il recupero del tono muscolare in soggetti immobilizzati
US5763408A (en) * 1992-06-03 1998-06-09 Fuji Photo Film Co., Ltd. Amino acid derivatives and application thereof
US5607691A (en) * 1992-06-12 1997-03-04 Affymax Technologies N.V. Compositions and methods for enhanced drug delivery
IT1277147B1 (it) * 1995-01-20 1997-11-04 Sigma Tau Ind Farmaceuti Uso della carnitina e i suoi derivati per ridurre gli effetti tossici della ciclosporina-a e di altri farmaci immunosoppressivi.
ATE187329T1 (de) * 1996-03-04 1999-12-15 Sigma Tau Ind Farmaceuti Carnitinderivat als arzneimittel zur behandlung von arteriosklerose obliterans
US6348495B1 (en) * 1996-06-06 2002-02-19 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Method for treating celiac disease
IT1291113B1 (it) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
IT1291127B1 (it) * 1997-04-01 1998-12-29 Sigma Tau Ind Farmaceuti Integratore alimentare per soggetti dediti ad intensa e prolungata attivita' fisica
US5922766A (en) * 1997-07-02 1999-07-13 Acosta; Phyllis J. B. Palatable elemental medical food
IT1302863B1 (it) 1998-11-13 2000-10-10 Sigma Tau Healthscience Spa Composizione ad attivita' antiossidante e preventiva di alterazionitrombotiche e aterosclerotiche comprendente una carnitina ed un
IT1306130B1 (it) * 1999-04-16 2001-05-30 Sigma Tau Healthscience Spa Composizione comprendente una carnitina e glutatione, atta adaumentare l'assorbimento del glutatione sinergizzandone gli effetti.
IT1306173B1 (it) * 1999-07-23 2001-05-30 Sigma Tau Healthscience Spa Composizione per la prevenzione degli affaticamenti muscolari e permigliorare il rendimento energetico muscolare.
IT1306722B1 (it) * 1999-10-08 2001-10-02 Sigma Tau Healthscience Spa Composizione per la prevenzione e/o il trattamento di disfunzionicircolatorie, comprendente derivati della l-carnitina ed estratti di
IT1307278B1 (it) * 1999-11-18 2001-10-30 Sigma Tau Healthscience Spa Composizione per la prevenzione e/o il trattamento di disturbi dovutiad un alterato metabolismo dei lipidi, che comprende propionil
IT1317062B1 (it) * 2000-07-14 2003-05-26 Sigma Tau Healthscience Spa Integratore alimentare utile per prevenire le disfunzioni epatiche ebiliari comprendente una alcanoil l-carnitina.
ITRM20010155A1 (it) * 2001-03-23 2002-09-23 Biosalts Srl Sale di creatina ad aumentato valore nutrizionale e terapeutico e composizioni che lo contengono.

Also Published As

Publication number Publication date
PL202682B1 (pl) 2009-07-31
HUP0300083A2 (hu) 2003-06-28
HUP0300083A3 (en) 2004-07-28
DE60122120T2 (de) 2007-02-08
ES2269356T3 (es) 2007-04-01
WO2001064204A2 (en) 2001-09-07
SK11892002A3 (sk) 2003-02-04
AU4103101A (en) 2001-09-12
ITRM20000107A0 (it) 2000-03-02
WO2001064204A3 (en) 2002-03-28
CA2400728A1 (en) 2001-09-07
CZ20022759A3 (cs) 2003-02-12
MXPA02008531A (es) 2003-02-12
ATE335476T1 (de) 2006-09-15
TNSN01032A1 (fr) 2005-11-10
US7897641B2 (en) 2011-03-01
CA2400728C (en) 2009-04-28
AU2001241031B8 (en) 2005-12-01
PL358267A1 (en) 2004-08-09
EP1267863A2 (en) 2003-01-02
AU2001241031B2 (en) 2005-10-27
DE60122120D1 (de) 2006-09-21
US20030144354A1 (en) 2003-07-31
IT1316998B1 (it) 2003-05-26
EP1267863B1 (en) 2006-08-09
DK1267863T3 (da) 2006-12-04
PT1267863E (pt) 2006-10-31
ITRM20000107A1 (it) 2001-09-02
CY1106169T1 (el) 2011-06-08

Similar Documents

Publication Publication Date Title
AR027968A1 (es) Una composicion para utilizar en el tratamiento y/o prevencion del sarampion y el uso de dicha composicion para un vehiculo para el tratamiento o prevencion del sarampion
AR028296A1 (es) Metodos sinergisticos y composiciones para el tratamiento del cancer
BR0207961A (pt) Combinação de análogos da epotilona e agentes quimioterápicos para o tratamento de doenças proliferativas
ECSP034774A (es) Pirazolopirimmidinas como agentes terapeuticos
ECSP034773A (es) Pirazolopirimmidinas como agentes terapeuticos
HUP0301194A3 (en) Pharmaceutical compositions containing combinations of depeptidyl peptidase iv inhibitors and other antidiabetic agents and their use for the treatment of diabete mellitus
MXPA02000282A (es) Composiciones de cuidado personal.
PA8503301A1 (es) Compuestos para el tratamiento de la isquemia
AR028512A1 (es) Composiciones antimicrobianas acidas para el tratamiento de alimentos y superficies que contactan alimentos y metodos para la utilizacion de estas
PT1181027E (pt) Composicao dietetica ou farmaceutica para utilizacao na prevencao ou tratamento de hiperoxaluria
HUP0400648A2 (hu) Ecteinascidin-743-t tartalmazó tumorellenes kezeléseknél alkalmazható készítmények
AR027945A1 (es) Uso de pramipexol en el tratamiento de transtornos de adiccion
UY27203A1 (es) Bencimidazoles útiles en el tratamiento de la disfunción sexual
CL2004001012A1 (es) Compuestos derivados de macrolidos de 14 o 15 miembros, sustituidos en posicion 4"; procedimiento para su preparacion; composicion farmaceutica que lo comprende; y su uso para el tratamiento o profilaxis de infecciones microbianas sistemicas o topica
AR018162A1 (es) Pirroles substituidos, composicion farmaceutica y el uso de los mismos para la preparacion de dicha composicion farmaceutica
BR0210101A (pt) Combinações antineoplásticas
AR030537A1 (es) Acidos quinolincarboxilicos y naftiridincarboxilico antibacterianos
AR025379A1 (es) 9a-azalidas con actividad antibacteriana.
BR0307085A (pt) Terapia combinada para o tratamento de infecções bacterianas
AR028359A1 (es) Composicion para el control de artropodos
AR027963A1 (es) Composicion para prevencion y/o tratamiento de los efectos citotoxicos inducidos por el uso de agentes inmunosupresores
PT1268482E (pt) Piranoindois para o tratamento de glaucoma
CL2004001007A1 (es) Compuestos derivados de macrolitos de 14 o 15 miembros, sustituidos en posicion 4"; procedimiento para su preparacion; composicion farmaceutica que lo comprende; y su uso para el tratamiento o profilaxis de infecciones microbianas sistemicas o topica
ES2196769T3 (es) Uso topico de loperamide para el tratamiento de infecciones microbianas.
CL2004001006A1 (es) Compuestos derivados de macrolidos de 14 o 15 miembros, sustituidos en posicion 4"; procedimiento para su preparacion; composicion farmaceuticas que lo comprende; y su uso para el tratamiento o profilaxis de infecciones microbianas sistemicas o topic

Legal Events

Date Code Title Description
FB Suspension of granting procedure